Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Hellerup – page 65

1 458 clinical trials in Hellerup, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hellerup at a glance
1 458
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 458 trials in Hellerup

Open in trial search

Study of trastuzumab deruxtecan treatment in patients with advanced HER2-positive breast cancer with or without brain metastases

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Trastuzumab Deruxtecan
  • Sponsor:AstraZeneca AB

Hot flush

Not recruiting

Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Fezolinetant
  • Sponsor:Astellas Pharma Global Development Inc.

Ovarian cancer

Not recruiting

Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AstraZeneca AB

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Obexelimab
  • Sponsor:Zenas Biopharma (USA) LLC

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Rheumatoid arthritis

Not recruiting

Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Methotrexate
  • Sponsor:Synact Pharma ApS

Migraine

Not recruiting

Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:MEDI0618
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Gastric cancer+1

Not recruiting

Study on Durvalumab and FLOT Chemotherapy for Patients with Resectable Gastric and Gastroesophageal Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AstraZeneca AB

Study on the Effects of Semaglutide in Patients with Early Alzheimer's Disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Psoriatic arthropathy

Not recruiting

Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Multiple sclerosis+1

Not recruiting

Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Methylprednisolone
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Hellerup

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on cardiovascular diseases including studies of new treatments for heart failure, atrial fibrillation, and atherosclerosis.

  • Heart failure treatment optimization
  • Stroke prevention strategies
  • Hypertension management

Current research examines novel therapeutic approaches like colchicine for heart conditions and innovative anticoagulation treatments.

02 Metabolic Disorders

Comprehensive studies addressing obesity and weight management through innovative therapeutic approaches and lifestyle interventions.

  • Weight reduction treatments
  • Diabetes management
  • Metabolic health optimization

Multiple trials are evaluating new medications including CagriSema and dapiglutide for weight management.

03 Respiratory Medicine

Advanced research in respiratory diseases including studies on vaccines and treatments for various pulmonary conditions.

  • Influenza prevention
  • COPD management
  • Pulmonary fibrosis treatments

Investigations include innovative approaches to lung disease treatment and prevention strategies.

04 Dermatological Studies

Clinical research focusing on skin conditions including treatments for psoriasis and atopic dermatitis.

  • Psoriasis therapies
  • Hidradenitis suppurativa treatment
  • Innovative dermatological interventions

Studies evaluate new biological treatments and their effectiveness in chronic skin conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.